Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
3
×
biotech
gene therapy
3
×
life sciences
national
national blog main
national top stories
new york top stories
novartis
san francisco top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
crispr
detroit blog main
detroit top stories
digital health
drug prices
fda
glaxosmithkline
indiana blog main
indiana top stories
medicare
new york blog main
nonalcoholic steatohepatitis
nusinersen
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
spinal muscular atrophy
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
What
new
3
×
bio
drug
remains
roundup
allogene
approval
approved
atrophy
biogen’s
biopharmaceutical
cancer
companies
convo
crispr
daily
diversity
earlier
evrysdi
failures
fda
friday
green
home
hot
immunotherapy
intended
investors
ipo
juno
lights
liquid
littered
medicine
million
muscular
nash
nearly
news
oral
Language
unset
Current search:
biogen
×
new
×
" gene therapy "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More